Home > Specialties > IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, CYP2D6

IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, CYP2D6

Definition : Molecular assay reagents intended to identify mutations in cytochrome P450, family 2, subfamily D, polypeptide 6 (CYP2D6) gene, located at chromosome 22q13.1, which is responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. The gene is involved in the metabolism of drugs such as antiarrhythmics, adrenoreceptor antagonists, and tricyclic antidepressants. Mutations at this locus have been identified in patients with poor metabolism of drugs, early-onset Parkinson's disease, ankylosing spondylitis, and leukemia.

Entry Terms : "Debrisoquine Sensitivity Gene Mutation Detection Reagents" , "Poor Drug Metabolism Gene Mutation Detection Reagents" , "CYP2D6 Gene Mutation Detection Reagents" , "Reagents, Molecular Assay, Gene Anomaly, Mutation, CYP2D6"

UMDC code : 24380

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-3 of 3 Match(es).

Assurex Health Inc

Company Type: Parent

Luminex Corp

Company Type: Parent

Luminex Corporation (NASDAQ: LMNX) was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex develops, manufactures and markets innovative biological testing technologies with applications throughout the diagnostic and life science industries.

Mayo Medical Laboratories

Company Type: Parent

1-3 of 3 Match(es).